Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

• Daniele Giardiello,
• Maartje J. Hooning,
• Michael Hauptmann,
• Renske Keeman,
• B. A. M. Heemskerk-Gerritsen,
• Heiko Becher,
• Carl Blomqvist,
• Stig E. Bojesen,
• Manjeet K. Bolla,
• Nicola J. Camp,
• Kamila Czene,
• Peter Devilee,
• Diana M. Eccles,
• Peter A. Fasching,
• Jonine D. Figueroa,
• Henrik Flyger,
• Montserrat García-Closas,
• Christopher A. Haiman,
• Ute Hamann,
• John L. Hopper,
• Anna Jakubowska,
• Floor E. Leeuwen,
• Annika Lindblom,
• Jan Lubiński,
• Sara Margolin,
• Maria Elena Martinez,
• Heli Nevanlinna,
• Ines Nevelsteen,
• Saskia Pelders,
• Paul D. P. Pharoah,
• Sabine Siesling,
• Melissa C. Southey,
• Annemieke H. van der Hout,
• Liselotte P. van Hest,
• Jenny Chang-Claude,
• Per Hall,
• Douglas F. Easton,
• Ewout W. Steyerberg,
• Marjanka K. Schmidt

Affiliations

Daniele Giardiello

Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital

Maartje J. Hooning

Department of Medical Oncology, Erasmus MC Cancer Institute

Michael Hauptmann

Brandenburg Medical School, Institute of Biostatistics and Registry Research

Renske Keeman

Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital

B. A. M. Heemskerk-Gerritsen

Department of Medical Oncology, Erasmus MC Cancer Institute

Heiko Becher

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf

Carl Blomqvist

Department of Oncology, Helsinki University Hospital, University of Helsinki

Stig E. Bojesen

Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital

Manjeet K. Bolla

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge

Nicola J. Camp

Department of Internal Medicine and Huntsman Cancer Institute, University of Utah

Kamila Czene

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

Peter Devilee

Department of Pathology, Leiden University Medical Center

Diana M. Eccles

Faculty of Medicine, University of Southampton

Peter A. Fasching

Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles

Jonine D. Figueroa

Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh

Henrik Flyger

Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital

Montserrat García-Closas

Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health

Christopher A. Haiman

Department of Preventive Medicine, Keck School of Medicine, University of Southern California

Ute Hamann

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ)

John L. Hopper

Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics, The University of Melbourne

Anna Jakubowska

Department of Genetics and Pathology, Pomeranian Medical University

Floor E. Leeuwen

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital

Annika Lindblom

Department of Molecular Medicine and Surgery, Karolinska Institutet

Jan Lubiński

Department of Genetics and Pathology, Pomeranian Medical University

Sara Margolin

Department of Oncology, Södersjukhuset

Maria Elena Martinez

Moores Cancer Center, University of California San Diego

Heli Nevanlinna

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki

Ines Nevelsteen

Department of Oncology, Leuven Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven

Saskia Pelders

Department of Medical Oncology, Erasmus MC Cancer Institute

Paul D. P. Pharoah

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge

Sabine Siesling

Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL)

Melissa C. Southey

Precision Medicine, School of Clinical Sciences at Monash Health, Monash University

Annemieke H. van der Hout

Department of Genetics, University Medical Center Groningen, University Groningen

Liselotte P. van Hest

Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam

Jenny Chang-Claude

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)

Per Hall

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

Douglas F. Easton

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge

Ewout W. Steyerberg

Department of Biomedical Data Sciences, Leiden University Medical Center

Marjanka K. Schmidt

Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital